At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 31 enrolled
Drug / intervention
X54 insulin pump with low suspend featuredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
United Kingdom User Evaluation, MiniMed Paradigm® X54 System
In Brief
A Phase 4 clinical trial evaluating X54 insulin pump with low suspend feature for Diabetes Mellitus, Type 1. Completed, enrolled 31 participants across 6 sites.
Detailed Summary
The user evaluation is to assess user acceptance and the quality of training materials for the MiniMed Paradigm® X54 System (X54 System) in preparation for commercial distribution of the new system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 1
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionFeb 2009
First PostedDec 2010
TodayJul 2026
First PostedDec 28, 2010
Enrollment StartJan 1, 2009
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 15.5 years ago
Interventions
X54 insulin pump with low suspend featuredevice
Change from current insulin pump to new X54 pump